Investing Profile

Shaan C. Gandhi

InvestorVC
Principal at Longwood Fund
northpondventures.com/team/Boston, Massachusetts
Photo of Shaan C. Gandhi, Principal at Longwood Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
273 CONNECTIONS
University of Oxford Network
158 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Case Western Reserve University Network
18 CONNECTIONS
cb
Longwood Fund Principal
$100K - $5.0M
$1.5M
Board Member DiCE MoleculesPresent
Board Member Garuda TherapeuticsPresent
Vice President and Head of Partnerships, PAVE PfizerPresent
Independent Board Member 1910Present
Vice President and Head of Strategic Partnerships, Pfizer Ignite PfizerPresent
Board Member Vigil NeurosciencePresent
Board Member DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and CompanyPresent
Board Member Transition Bio, Inc.Present
Board Member Kyverna TherapeuticsPresent
Board Member Opna BioPresent
Board Member Totus MedicinesPresent
Board Member Incendia TherapeuticsPresent
Board Member Mestag TherapeuticsPresent
Board Member Stratus TherapeuticsPresent
Board Member CAMP4 TherapeuticsPresent
Board Member StrideBio, IncPresent
Board Member TeckroPresent
Board Member Candel TherapeuticsPresent
Director Northpond VenturesPresent
Board Member Aro BiotherapeuticsPresent
Board Member Triumvira Immunologics, Inc.Present
Co-Founder and President Pyxis OncologyPresent
Principal Longwood FundPresent
Assistant in Medicine Massachusetts General HospitalPresent
Instructor Harvard Medical SchoolPresent
Resident Physician in Internal Medicine Massachusetts General HospitalPresent
Clinical Fellow in Medicine Harvard Medical SchoolPresent
Summer Associate McKinsey & CompanyPresent
Case Western Reserve University BS Biochemistry
University of Oxford DPhil Medical Oncology